MarkCurrieMD

Physician

Dr. Currie is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University at BuffaloFellowship, Hematology and Medical Oncology, 1982 - 1983
Duke University HospitalFellowship, Hematology and Medical Oncology, 1981 - 1982
Duke University HospitalResidency, Internal Medicine, 1978 - 1981
University of Texas Southwestern Medical SchoolClass of 1978

PubMed

267 citations
Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase
Jean-Pierre Pelletier, Dragan V. Jovanovic, Julio Cesar B. Fernandes, Pamela T. Manning, Jane R. Connor
Arthritis and Rheumatism. 1998-07-01
431 citations
Purification and sequence analysis of bioactive atrial peptides (atriopeptins)
Mark G. Currie, David M. Geller, Barbara R. Cole, Ned R. Siegel, Kam F. Fok
Science. 1984-01-06
283 citations
A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With ...
Satish S.C. Rao, Anthony Lembo, S J Shiff, Bernard J. Lavins, Mark G. Currie
The American Journal of Gastroenterology. 2012-11-01

Peelable Thermal Interface Material (TIM) from Henkel Recognized with Industry AccoladeDecember 11th, 2018
Ironwood Pharmaceuticals Promotes Dr. Mark Currie to Senior Vice President, Chief Scientific Officer, and President of R&DFebruary 11th, 2013